Patents Assigned to Alkahest, Inc.
  • Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products
    Patent number: 10357513
    Abstract: Methods and compositions for treating and/or preventing aging-related conditions are described. The compositions used in the methods include blood plasma and blood plasma fractions derived from blood plasma with efficacy in treating and/or preventing aging-related conditions such as cognitive disorders. The methods relate to a regimen of pulsed dosing of blood plasma or blood plasma fractions.
    Type: Grant
    Filed: April 24, 2018
    Date of Patent: July 23, 2019
    Assignee: Alkahest, Inc.
    Inventors: Steven P. Braithwaite, Eva Czirr, Ian Gallager, Nina Huber, S. Sakura Minami
  • Blood plasma and plasma fractions as therapy for tumor growth and progression
    Patent number: 10245285
    Abstract: The invention relates to treating individuals with cancer by using blood plasma or blood plasma fractions as treatment.
    Type: Grant
    Filed: April 27, 2017
    Date of Patent: April 2, 2019
    Assignee: Alkahest, Inc.
    Inventors: Steven P. Braithwaite, S. Sakura Minami, Joseph McCracken
  • Pharmaceutical formulations comprising CCR3 antagonists
    Patent number: 10213421
    Abstract: The present invention relates to pharmaceutical compositions containing one or more compounds of formula 1 wherein R1 is H, C1-6-alkyl, C0-4-alkyl-C3-6-cycloalkyl, C1-6-haloalkyl; R2 is H, C1-6-alkyl; X is an anion selected from the group consisting of chloride or ½ dibenzoyltartrate j is 1 or 2. processes for the preparation thereof, and their use to treat diseases connected with the CCR3 receptor.
    Type: Grant
    Filed: March 27, 2013
    Date of Patent: February 26, 2019
    Assignee: Alkahest, Inc.
    Inventors: Alfred Fetscher, Jochen Matthias Scher